247.5MUSD
-0.42
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US29428V1044
CUSIP
29428V104
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
-
Book Value
0.85
Dividend Share
0
Dividend Yield
0.00%
Earnings Share
-2.087
Wall Street Target Price
6.00
EPS Estimate Current Year
-1.89
EPS Estimate Next Year
-2.19
EPS Estimate Current Quarter
-0.36
EPS Estimate Next Quarter
-0.31
Most Recent Quarter
-
Revenue TTM
53,010,000
Gross Profit TTM
18,569,000
EBITDA
-188,424,992
Profit Margin
0.00%
Return On Assets TTM
-39.25%
Return On Equity TTM
-877.48%
Revenue Per Share TTM
0.409
Qtly Revenue Growth YOY
111.60%
Diluted Eps TTM
-2.087
Qtly Earnings Growth YOY
0.00%
Trailing PE
0.00
Forward PE
0
Price Sales TTM
4.6689
Price Book MRQ
14.8412
Enterprise Value Revenue
6
Enterprise Value EBITDA
-1
109.85
1.76%152.73
1.13%79.96
0.99%30.49
0.68%459.27
0.51%90.00
0.00%182.50
0.00%3.18
0.00%69.15
-0.89%546.11
-0.28%